Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

BNTX

BioNTech SE ADR

Oct 15 • 04:00PM ET

117.53

Dollar change -2.61
Percentage change -2.17	%

Healthcare • Biotechnology • Germany • NASD

Peers: MRNA PFE NVAX AZN JNJ GSK BMY GILD LLY SNY

| Held by: IBB FBT FNDF BBH SPDW IDNA QQQJ GNOM ONEQ KOMP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.32	Insider Own	0.26%	Shs Outstand	237.73M	Perf Week	-2.30%
Market Cap	27.94B	Forward P/E	-	EPS next Y	-3.31	Insider Trans	0.00%	Shs Float	237.11M	Perf Month	-4.81%
Income	-544.48M	PEG	-	EPS next Q	-1.55	Inst Own	17.88%	Short Float	0.78%	Perf Quarter	35.92%
Sales	2.91B	P/S	9.61	EPS this Y	-165.65%	Inst Trans	-0.52%	Short Ratio	1.96	Perf Half Y	36.12%
Book/sh	85.98	P/B	1.37	EPS next Y	-20.85%	ROA	-2.26%	Short Interest	1.86M	Perf Year	13.47%
Cash/sh	46.78	P/C	2.51	EPS next 5Y	-	ROE	-2.58%	52W Range	76.53 - 131.49	Perf YTD	11.36%
Dividend Est.	-	P/FCF	9.35	EPS past 5Y	-	ROI	-2.63%	52W High	-10.62%	Beta	0.24
Dividend TTM	-	Quick Ratio	7.40	Sales past 5Y	843.27%	Gross Margin	82.90%	52W Low	53.57%	ATR (14)	4.02
Dividend Ex-Date	Jun 02, 2022	Current Ratio	7.54	EPS Y/Y TTM	-112.44%	Oper. Margin	-20.10%	RSI (14)	57.04	Volatility	2.41% 3.38%
Employees	3082	Debt/Eq	0.01	Sales Y/Y TTM	-69.08%	Profit Margin	-18.73%	Recom	1.79	Target Price	130.82
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-323.29%	Payout	0.00%	Rel Volume	0.60	Prev Close	120.14
Sales Surprise	-3.82%	EPS Surprise	-67.53%	Sales Q/Q	-24.09%	Earnings	Aug 05 BMO	Avg Volume	949.67K	Price	117.53
SMA20	-0.38%	SMA50	14.86%	SMA200	24.28%	Trades		Volume	568,397	Change	-2.17%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-24-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$93 → $145
Sep-17-24	Upgrade	Jefferies	Hold → Buy	$96 → $150
Sep-16-24	Upgrade	JP Morgan	Underweight → Neutral	$91 → $125
Aug-07-24	Upgrade	Deutsche Bank	Hold → Buy	$95
Aug-02-24	Upgrade	HSBC Securities	Hold → Buy
May-14-24	Initiated	Evercore ISI	In-line	$100
Feb-23-24	Initiated	BMO Capital Markets	Outperform	$127
Jan-05-24	Initiated	Oppenheimer	Perform
Dec-01-23	Downgrade	JP Morgan	Neutral → Underweight	$106 → $99
Oct-16-23	Downgrade	HSBC Securities	Buy → Hold	$124 → $111
Jul-14-23	Initiated	HSBC Securities	Buy	$124
May-17-23	Upgrade	Redburn	Neutral → Buy	$165 → $170
Dec-15-22	Upgrade	BofA Securities	Neutral → Buy	$239
Aug-17-22	Initiated	Cowen	Market Perform	$177
Jul-13-22	Upgrade	SVB Leerink	Mkt Perform → Outperform
Jul-06-22	Resumed	Canaccord Genuity	Buy	$192
Feb-01-22	Upgrade	Redburn	Sell → Neutral
Dec-16-21	Initiated	Morgan Stanley	Equal-Weight	$294
Nov-10-21	Upgrade	H.C. Wainwright	Neutral → Buy	$360
Oct-22-21	Initiated	Deutsche Bank	Hold	$250

Show Previous Ratings

Oct-14-24 11:13PM	'Where we are today in biology AI is similar to GPT in 2020': An interview with the CEO of Africa's biggest AI startup (TechCrunch)
Oct-08-24 05:50AM	Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents (Reuters)
Oct-07-24 01:00PM	Starboard Value takes $1 billion stake in Pfizer: Reports (Yahoo Finance)
Oct-01-24 06:00AM	BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day (GlobeNewswire)
Sep-25-24 11:13AM	As GSK discontinues HSV vaccine, opportunities remain for Moderna and BioNTech (Clinical Trials Arena)
08:11AM	Loading…
Sep-20-24 08:11AM	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union (Business Wire)
Sep-19-24 12:02PM	BioNTech Is More Than a Covid-19 Stock. Its Having a Great September. (Barrons.com)
05:12AM	Mpox: Three ongoing vaccine trials to watch (Clinical Trials Arena)
Sep-17-24 04:09PM	How BioNTech, Up 26% Over Four Days, Is Riding Summit's Coattails To A Recovery (Investor's Business Daily) -7.29%
06:45AM	BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024 (GlobeNewswire)
04:24AM	Here's Why Everyone's Talking About Summit Therapeutics (Motley Fool)
Sep-13-24 06:41PM	Analyst Report: BioNTech SE (Morningstar Research) +17.52%
09:34AM	BioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar? (Zacks)
06:12AM	ESMO 2024: Modernas mRNA solid tumour vaccine shows early promise (Clinical Trials Arena)
Sep-05-24 07:15AM	BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024 (GlobeNewswire)
09:15AM	Loading…
Sep-04-24 09:15AM	New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth (GlobeNewswire)
08:30AM	Tempus Announces Real World Data Collaboration with BioNTech (Business Wire)
Aug-26-24 06:52AM	BioNTech initiates global trials of mRNA-based lung cancer vaccine (Clinical Trials Arena)
Aug-23-24 02:01PM	The FDA Approved New Covid Vaccines. Should You Get One? (The Wall Street Journal)
Aug-22-24 02:33PM	FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot (Benzinga)
02:15PM	Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine (Business Wire)
01:44PM	The FDA Approved a New Covid Vaccine. Should You Get It? (The Wall Street Journal)
Aug-21-24 12:12AM	Pfizer forecasts $26bn of Covid-19 vaccine revenue after first-quarter success (Pharmaceutical Technology)
Aug-20-24 05:52AM	FDA greenlights BioNTech/Medilinks cancer trial at lower dose after deaths (Clinical Trials Arena)
Aug-19-24 09:39AM	FDA Allows Resumption Of BioNTech/MediLink Therapeutics Partnered Phase 1 Study For Cancer Drug With Lower Dose (Benzinga) +5.56%
08:05AM	FDA lifts partial hold on study of BioNTech-partnered ADC (BioPharma Dive)
04:07AM	Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell? (Motley Fool)
Aug-16-24 11:12PM	Pfizer and BioNTechs Covid-19/flu combination vaccine falters in Phase III readout (Clinical Trials Arena)
04:21PM	Pfizer, BioNTech hit roadblock in COVID-flu vaccine trial (Yahoo Finance Video)
04:08PM	Pfizer Slides Toward Sell Zone After BioNTech-Tied Covid/Flu Shot Misses Its Mark (Investor's Business Daily)
01:29PM	Loading…
01:29PM	Pfizer, BioNTech Combination Flu and COVID-19 Shot Misses 1 of 2 Endpoints (Investopedia)
10:21AM	Pfizers Stumble on Flu and Covid Shot Is a Plus for Moderna (Barrons.com)
08:20AM	Pfizer, BioNTech stumble in effort to develop combination flu, COVID shot (BioPharma Dive)
06:45AM	Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age (GlobeNewswire)
Aug-13-24 02:43PM	Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows (Benzinga)
Aug-08-24 06:40AM	3 Biotech Stocks With Promising Drug Pipelines: August 2024 (InvestorPlace)
Aug-05-24 02:30PM	BioNTech Se (BNTX) Q2 2024 Earnings Call Transcript (Motley Fool)
01:24PM	Analyst Report: BioNTech SE (Morningstar Research)
11:53AM	BioNTech exits PD-L1 development with Genmab as Q2 revenues drop (Pharmaceutical Technology)
10:28AM	BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls (Investopedia)
07:59AM	BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products (Benzinga)
06:02AM	BioNTech counts on shift to cancer drugs after second quarter losses quadruple (Reuters)
05:59AM	BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update (GlobeNewswire)
Jul-30-24 06:52AM	BioNTech's cancer drug meets primary endpoint in Phase 2 trial (Reuters)
06:45AM	BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced Melanoma (GlobeNewswire)
Jul-24-24 06:33AM	Triastek and BioNTech to develop 3D-printed RNA therapeutics (Pharmaceutical Technology)
Jul-22-24 06:45AM	BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024 (GlobeNewswire)
Jul-02-24 08:00AM	3 Nasdaq Stocks to Sell in July Before They Crash & Burn (InvestorPlace)
Jul-01-24 11:00PM	Surprise! 3 Stocks That Are Outperforming Nvidia in 2024. (InvestorPlace)
12:34PM	Lab to jab in 100 days: manufacturing flexibility for future rapid responses (Pharmaceutical Technology)
12:19PM	3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks (InvestorPlace)
Jun-28-24 04:32AM	CHMP recommends authorisation for Pfizer-BioNTechs Covid-19 vaccine (Pharmaceutical Technology)
Jun-27-24 10:30AM	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union (GlobeNewswire)
Jun-24-24 06:45AM	BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer (GlobeNewswire)
Jun-18-24 11:53AM	FDA puts partial clinical hold on BioNTechs ADC trial after fatalities (Clinical Trials Arena)
10:19AM	Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment (Benzinga)
Jun-17-24 11:50AM	BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay (Bloomberg)
Jun-03-24 03:41PM	FDA considers updating COVID boosters, Novavax stock reacts (Yahoo Finance Video)
09:17AM	Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates (PR Newswire)
04:45AM	Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC (Clinical Trials Arena)
Jun-01-24 10:00AM	Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) (Business Wire)
May-31-24 07:15AM	NHS launches personalised mRNA cancer vaccines trial (Clinical Trials Arena)
May-30-24 04:25AM	BioNTech and CEPI expand deal to boost Africas vaccine capabilities (Pharmaceutical Technology) +5.92%
May-29-24 08:00AM	BioNTech and CEPI Expand Partnership to Strengthen Africa's mRNA Vaccine Ecosystem (GlobeNewswire)
May-26-24 08:00PM	MediLink Therapeutics announces a multi-target TMALIN ADC technology platform license agreement with BioNTech, expanding their global strategic partnership (PR Newswire)
May-24-24 12:16PM	Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More (PR Newswire)
08:15AM	Why Vaccine Stocks Rallied This Week (Motley Fool)
May-21-24 06:45AM	BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024 (GlobeNewswire)
04:00AM	Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term (GlobeNewswire)
May-20-24 02:09PM	3 Blue-Chip Stocks Set to Triple Soon (InvestorPlace)
May-18-24 02:42AM	Q1 2024 Autolus Therapeutics PLC Earnings Call (Thomson Reuters StreetEvents)
May-17-24 02:46PM	European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech (Benzinga)
01:17PM	Update: Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech (MT Newswires)
12:36PM	Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech (MT Newswires)
11:15AM	BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024 (GlobeNewswire)
May-14-24 07:58AM	Evercore ISI Starts BioNTech With In Line Rating, $100 Price Target (MT Newswires)
May-07-24 11:26AM	BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript (Insider Monkey)
06:22AM	BioNTech reports net loss of 315.1m in Q1 2024 (Pharmaceutical Technology)
05:08AM	Q1 2024 BioNTech SE Earnings Call (Thomson Reuters StreetEvents)
May-06-24 04:14PM	BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come (Investor's Business Daily)
04:04PM	Analyst Report: BioNTech SE (Morningstar Research)
02:30PM	BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript (Motley Fool)
12:11PM	BioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents Topline (MT Newswires)
12:02PM	What's Going With BioNTech Stock On Monday? (Benzinga)
11:53AM	BNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
10:16AM	BioNTech Seesaws As Covid Sales Plummet With 90% Of Revenue Still To Come (Investor's Business Daily)
08:57AM	BioNTech Slides After Reporting Losses As Covid Vaccine Sales Take A Hit (Investor's Business Daily)
08:15AM	Sector Update: Health Care (MT Newswires)
07:31AM	BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales (Barrons.com)
07:23AM	BioNTech Swings to Q1 Loss, Revenue Falls -- Shares Decline Pre-Bell (MT Newswires)
07:03AM	UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year (Reuters)
07:03AM	BioNTech Slips To Loss In Q1 (RTT News)
06:49AM	BioNTech says 90% of 2024 revenues will accrue at end of year (Reuters)
06:45AM	BioNTech Announces First Quarter 2024 Financial Results and Corporate Update (GlobeNewswire)
May-03-24 10:08AM	Why Earnings Season Could Be Great for BioNTech (BNTX) (Zacks)
Apr-30-24 11:58AM	BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store? (Zacks)
Apr-25-24 01:51PM	Sector Update: Health Care Stocks Drop in Afternoon Trading (MT Newswires)
01:28PM	Wall Street plunges after US inflation shock (The Telegraph)
12:55PM	Update: GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines (MT Newswires)
11:27AM	GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines (MT Newswires)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
ATHOS KG	10% Owner	Oct 14 '24	Proposed Sale	120.83	25,424	3,071,964	Oct 15 08:41 AM
ATHOS KG	10% Owner	Oct 11 '24	Proposed Sale	120.13	40,000	4,805,228	Oct 11 04:15 PM
ATHOS KG	10% Owner	Oct 10 '24	Proposed Sale	117.47	20,000	2,349,436	Oct 10 04:13 PM
ATHOS KG	10% Owner	Oct 09 '24	Proposed Sale	119.06	6,000	714,361	Oct 09 04:02 PM
ATHOS KG	10% Owner	Oct 08 '24	Proposed Sale	122.01	15,000	1,830,100	Oct 08 04:24 PM
ATHOS KG	10% Owner	Oct 04 '24	Proposed Sale	122.80	14,756	1,812,078	Oct 04 04:17 PM
ATHOS KG	10% Owner	Oct 03 '24	Proposed Sale	119.27	50,000	5,963,585	Oct 03 05:14 PM
ATHOS KG	10% Owner	Oct 02 '24	Proposed Sale	119.04	65,200	7,761,193	Oct 02 06:18 PM
ATHOS KG	10% Owner	Oct 01 '24	Proposed Sale	119.24	72,086	8,595,657	Oct 01 04:18 PM
ATHOS KG	10% Owner	Sep 30 '24	Proposed Sale	118.22	76,114	8,998,197	Sep 30 04:52 PM
ATHOS KG	10% Owner	Sep 27 '24	Proposed Sale	117.64	37,204	4,376,679	Sep 27 05:12 PM
ATHOS KG	10% Owner	Sep 25 '24	Proposed Sale	118.47	37,943	4,495,107	Sep 25 07:14 PM
ATHOS KG	10% Owner	Sep 18 '24	Proposed Sale	124.71	55,605	6,934,500	Sep 18 07:28 PM
ATHOS KG	10% Owner	Sep 17 '24	Proposed Sale	124.49	30,162	3,754,792	Sep 17 04:14 PM
ATHOS KG	10% Owner	Sep 16 '24	Proposed Sale	123.40	500,000	61,700,000	Sep 16 05:35 PM
ATHOS KG	10% Owner	Sep 16 '24	Proposed Sale	126.02	90,000	11,341,611	Sep 16 04:12 PM
ATHOS KG	10% Owner	Sep 13 '24	Proposed Sale	115.02	170,000	19,552,584	Sep 13 04:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNTX

BioNTech SE ADR

Upgrade your FINVIZ experience